Alpha Tau Medical Ltd. DRTS

Set alert

Price alert · DRTS

All alert types
12.83 USD -0.23 -1.76%

At close

13.17 +0.34 +2.65%

Pre-market · Nov 3, 8:46 AM ET

Bid
12.83 × 7
Ask
12.84 × 8
12.67 Day range 13.23
3.43 52-week range 15.79
YTD
+159.19%
1 year
+227.30%
Open
13.22
Prev close
13.06
Mkt cap
1.19B
Vol
436.84K
Avg vol
531.13K
EPS
-1.04
P/E
0.00
Div yield
0.00%
More statistics
Low
12.67
High
13.23
Forward P/E
-24.00
Beta
1.29
Short ratio
7.22
Inst. own
9.26%
Dividend
0.00
Ex-div date
Earnings
Nov 19, 2026
50-d avg
14.26
200-d avg
10.60
1y target
17.80

5D chart

Chart tools
Interval

Signals (105)
NameTimeAgo
RSI: OverboughtOct 30, 3:50 PM3 days ago
SMA: BullishOct 30, 3:05 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
MACD: Buy SignalOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 1:00 PM3 days ago
SMA: BullishOct 30, 12:40 PM3 days ago
MACD: Sell SignalOct 30, 12:30 PM3 days ago
SMA: BearishOct 30, 12:00 PM3 days ago
SMA: BullishOct 30, 11:05 AM3 days ago
MACD: Buy SignalOct 30, 10:35 AM3 days ago
RSI: OversoldOct 30, 9:35 AM4 days ago
SMA: BearishOct 30, 9:30 AM4 days ago
SMA: BearishOct 30, 9:30 AM4 days ago
MACD: Sell SignalOct 30, 9:30 AM4 days ago
SMA: BullishOct 29, 3:30 PM4 days ago
MACD: Buy SignalOct 29, 2:25 PM4 days ago
MACD: Sell SignalOct 29, 2:20 PM4 days ago
MACD: Buy SignalOct 29, 2:05 PM4 days ago
MACD: Sell SignalOct 29, 1:55 PM4 days ago
SMA: BullishOct 29, 1:30 PM4 days ago

Newest 20 of 105.

Financial health

Altman Z-Score

4.83 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -9.3×
FY 2019: -77.7×FY 2020: -77.7×FY 2021: -24.6×FY 2022: -6.0×FY 2023: -7.1×FY 2024: -6.9×FY 2025: -9.3×
FY 2019 5y median -7.1× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 5.2×
FY 2019: -3539×FY 2020: -81.0×FY 2021: -19.1×FY 2022: 1.9×FY 2023: 2.5×FY 2024: 3.5×FY 2025: 5.2×
FY 2019 5y median 2.5× FY 2025
P/FCF -12.2×
FY 2019: -83.3×FY 2020: -62.0×FY 2021: -45.1×FY 2022: -8.2×FY 2023: -8.5×FY 2024: -9.8×FY 2025: -12.2×
FY 2019 5y median -9.8× FY 2025
EV/EBITDA -9.7×
FY 2019: -85.7×FY 2020: -78.8×FY 2021: -26.2×FY 2022: -6.1×FY 2023: -7.5×FY 2024: -7.1×FY 2025: -9.7×
FY 2019 5y median -7.5× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -8.2%
FY 2019: -1.2%FY 2020: -1.6%FY 2021: -2.2%FY 2022: -12.3%FY 2023: -11.7%FY 2024: -10.2%FY 2025: -8.2%
FY 2019 5y median -10.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -55.3%
FY 2019: 4385.5%FY 2020: 105.4%FY 2021: 78.4%FY 2022: -32.0%FY 2023: -34.5%FY 2024: -50.7%FY 2025: -55.3%
FY 2019 5y median -34.5% FY 2025
ROIC -43.5%
FY 2019: -26.5%FY 2020: -18.2%FY 2021: -36.5%FY 2022: -27.6%FY 2023: -35.2%FY 2024: -45.9%FY 2025: -43.5%
FY 2019 5y median -36.5% FY 2025
ROA -40.0%
FY 2019: -26.8%FY 2020: -16.8%FY 2021: -64.6%FY 2022: -28.1%FY 2023: -27.2%FY 2024: -36.8%FY 2025: -40.0%
FY 2019 5y median -36.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -17.3%
FY 2019: 0.0%FY 2020: -15.4%FY 2021: -49.2%FY 2022: -133.0%FY 2023: -11.0%FY 2024: -1.0%FY 2025: -17.3%
FY 2019 FY 2025
EPS (diluted) -17.8%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: -207.7%FY 2022: -32.5%FY 2023: 20.8%FY 2024: -7.1%FY 2025: -17.8%
FY 2019 FY 2025
Free Cash Flow -48.7%
FY 2019: 0.0%FY 2020: -34.3%FY 2021: -33.8%FY 2022: -68.1%FY 2023: 1.7%FY 2024: 9.6%FY 2025: -48.7%
FY 2019 FY 2025

Financial Health

Current Ratio 7.5×
FY 2019: 22.1×FY 2020: 22.7×FY 2021: 7.4×FY 2022: 24.5×FY 2023: 12.1×FY 2024: 7.4×FY 2025: 7.5×
FY 2019 5y median 7.5× FY 2025
Quick Ratio 7.5×
FY 2019: 21.3×FY 2020: 22.7×FY 2021: 9.3×FY 2022: 24.5×FY 2023: 12.1×FY 2024: 7.4×FY 2025: 7.5×
FY 2019 5y median 9.3× FY 2025
Debt / Equity 0.2×
FY 2019: 0.0×FY 2020: -6.4×FY 2021: -1.6×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 0.1×
FY 2019: 0.2×FY 2020: -4.2×FY 2021: -1.2×FY 2022: 0.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2019 5y median 0.0× FY 2025
Interest Coverage -101×
FY 2019: 0.0×FY 2020: -42.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -476×FY 2024: -119×FY 2025: -101×
FY 2019 5y median -101× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31